741699-04-7 Usage
Uses
Used in Pharmaceutical Research:
3-Ethoxy-4-iodobenzoic acid ethyl ester is used as an intermediate in pharmaceutical research for the development of new drugs. Its unique chemical structure and properties make it a valuable building block in the synthesis of more complex organic molecules with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Ethoxy-4-iodobenzoic acid ethyl ester is utilized as a key intermediate for the preparation of various organic compounds. Its reactivity and solubility in organic solvents facilitate its use in a wide range of chemical reactions and processes in the laboratory.
Used in Agrochemical Development:
3-Ethoxy-4-iodobenzoic acid ethyl ester also has potential applications in the development of agrochemicals. Its chemical properties can be harnessed to create new compounds with pesticidal or herbicidal properties, contributing to advancements in agricultural chemistry and crop protection.
Check Digit Verification of cas no
The CAS Registry Mumber 741699-04-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,6,9 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 741699-04:
(8*7)+(7*4)+(6*1)+(5*6)+(4*9)+(3*9)+(2*0)+(1*4)=187
187 % 10 = 7
So 741699-04-7 is a valid CAS Registry Number.
741699-04-7Relevant articles and documents
AMPA RECEPTOR POTENTIATORS
-
Page/Page column 5, (2010/11/25)
The present invention relates to AMPA receptor potentiators of Formula I: formulations comprising them, methods for their use, and intermediates useful for their preparation.
AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF
-
Page/Page column 28, (2008/06/13)
The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 and R2 are each hydrogen or lower alkyl; R3 R4, R5 and R6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R7 and R8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R9 is -C(O)-R10, -A1-C(O)-R10, -O-A2-C(O)-R10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
